Basal Insulin Toujeo SoloStar: Primary Qualities and New Prospects of Glycemic Control Achieving
نویسندگان
چکیده
منابع مشابه
The effects of correction insulin and basal insulin on inpatient glycemic control.
Hospitalized patients with type 2 diabetes may benefit from tighter glycemic control to prevent hyperglycemia and its complications. The glycemic control of two groups of inpatients with diabetes receiving subcutaneous insulin via a basal-bolus approach or sliding scale was compared.
متن کاملBarriers to Achieving Glycemic Targets: Who Omits Insulin and Why?
Improved glycemic control in people with diabetes delays the onset and progression of severe microvascular complications of diabetes (1,2). Despite advances in pharmacotherapy and diabetes treatment devices and the emphasis placed on treatment adherence over the last decade, National Health and Nutrition Examination Survey (NHANES) data showed 45% of patients with diabetes did not achieve glyce...
متن کاملMultifaceted Determinants for Achieving Glycemic Control
OBJECTIVE The International Diabetes Mellitus Practice Study is a 5-year survey documenting changes in diabetes treatment practice in developing regions. RESEARCH DESIGN AND METHODS Logistic regression analysis was used to identify factors for achieving A1C <7% in 11,799 patients (1,898 type 1 diabetic and 9,901 type 2 diabetic) recruited by 937 physicians from 17 countries in Eastern Europe ...
متن کاملGlycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis
BACKGROUND When target glycated hemoglobin (HbA1c) levels are not reached, basal insulin therapy should be considered in type 2 diabetes. The objective of this report was to describe the predictors of glycemic control (strict criterion: HbA1c ≤6.5%) during the first year after initiating basal insulin therapy in primary care. METHODS The study applied a retrospective approach using a nationwi...
متن کاملPramlintide improved glycemic control and reduced weight in patients with type 2 diabetes using basal insulin.
OBJECTIVE To assess the efficacy and safety of pramlintide in patients with type 2 diabetes suboptimally controlled with basal insulin. RESEARCH DESIGN AND METHODS In a 16-week, double-blind, placebo-controlled study, 212 patients using insulin glargine with or without oral antidiabetes agents (OAs) were randomized to addition of pramlintide (60 or 120 microg b.i.d./t.i.d.) or placebo. Insuli...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: INTERNATIONAL JOURNAL OF ENDOCRINOLOGY
سال: 2016
ISSN: 2307-1427,2224-0721
DOI: 10.22141/2224-0721.3.75.2016.76640